Sign In
Buy A
$141.11
+1.91 (+1.37%)
At Close: Aug 05, 2026
Why Is Agilent (A) Up 2.4% Since Last Earnings Report?
12:03pm, Wednesday, 23'rd Dec 2020
Agilent (A) reported earnings 30 days ago. What's next for the stock?
Agilent Receives Approval for GenetiSure Dx Postnatal Assay in Japan
10:00pm, Tuesday, 22'nd Dec 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced it has obtained clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx Post
Agilent Announces Webcasts for Investment Community
11:00am, Wednesday, 16'th Dec 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces investor webcasts.
Agilent Receives Multiple Innovation Awards
08:00am, Monday, 14'th Dec 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that both the NanoDis System and the innovative new style polychromator in the 5800 and 5900 ICP-OES have rece
Agilent Releases 2019 Corporate Social Responsibility Report
10:00am, Friday, 11'th Dec 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent releases 2019 corporate social responsibility report.
Agilent Presents Thought Leader Award to IIT Delhi Scientist Professor Anurag Rathore
12:30am, Monday, 07'th Dec 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has honored Prof. Anurag Rathore, a scientist at the Indian Institute of Technology (IIT) Delhi, with an Agilent Thought Leade
Agilent Announces Alissa Interpret Selected by North West Genomic Laboratory Hub for Clinical Genomic Analysis
08:00am, Thursday, 03'rd Dec 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its clinical informatics platform Alissa Interpret has been adopted by the North West Genomic Laboratory Hub (
Agilent Announces Launch of Global Biomarker Pathologist Training Program
08:00am, Monday, 30'th Nov 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Biomarker Pathologist Training Program, a global initiative created to empower pathologists
Agilent Technologies Inc. (A) CEO Mike McMullen on Q4 2020 Results - Earnings Call Transcript
08:15pm, Monday, 23'rd Nov 2020
Agilent Technologies Inc. (A) CEO Mike McMullen on Q4 2020 Results - Earnings Call Transcript
Agilent Technologies: Q4 Earnings Insights
04:29pm, Monday, 23'rd Nov 2020
Shares of Agilent Technologies (NYSE:A) fell 2.53% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 10.11% over the past year to $0.98, which be
Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results; Initiates Fiscal 2021 Guidance
04:05pm, Monday, 23'rd Nov 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent reports fourth-quarter and fiscal year 2020 financial results; initiates fiscal 2021 guidance.
Dividend Changes: November 14-20, 2020
09:00am, Monday, 23'rd Nov 2020
In this article series, we provide a weekly summary of dividend changes. A summary table provides relevant data and key statistics of dividend increases.
Agilent Launches New NanoDis System for Nanoparticle Dissolution Testing
08:00am, Monday, 23'rd Nov 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation
Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
08:32am, Tuesday, 17'th Nov 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced professors Carl H. June, MD, and Michael Milone, MD, Ph.D., as recipients of an Agilent Thought Leader Award.
Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 pharmDx in Triple-Negative Breast Cancer
08:26pm, Friday, 13'th Nov 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as an aid in identifying patients with trip
